-
Mashup Score: 1JPM22, Day 3: What's next for Morgan Health, Sharecare focuses on diversifying as EBITDA lags and more - 2 year(s) ago
BCBS Massachusetts is incorporating data and progress metrics into payment models. Over the next three years, the organization expects to incorporate financial incentives around closing racial inequities, one executive said.
Source: FierceHealthcareCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1JPM22, Day 2: One Medical touts membership model, Tenet says it's full steam ahead on ASCs and more - 2 year(s) ago
Tenet’s ambulatory surgery subsidiary is the chain’s “gem for the future” and on track to claim the majority of the company’s adjusted EBITDA mix in the next few years, CEO Suam Sutaria said at the virtual conference.
Source: FierceHealthcareCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0JPM22, Day 2: One Medical touts membership model, Tenet says it's full steam ahead on ASCs and more - 2 year(s) ago
Tenet’s ambulatory surgery subsidiary is the chain’s “gem for the future” and on track to claim the majority of the company’s adjusted EBITDA mix in the next few years, CEO Suam Sutaria said at the virtual conference.
Source: FierceHealthcareCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 12021 Year-End Insights Report: $44B Raised Globally in Health Innovation, Doubling Year Over Year - 2 year(s) ago
Thanks to a wave of mega deals in the United States, England, India, and China, health innovation funding has reached heights that would…
Source: MediumCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2JPM 2022: Abbott, iRhythm, Novocure, Zimmer Biomet - 2 year(s) ago
The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022 as they continue to cope with the impact of the Omicron surge. Here are some of the highlights from the presentations on the second day of the meeting.
Source: Medtech InsightCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 5Reporter's notebook: J.P. Morgan's 2022 health conference - 2 year(s) ago
Day 2 included presentations from UHS, CVS and Abbott Laboratories.
Source: Modern HealthcareCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1JPM 2022: CVS Health boosts 2021 guidance on back of stronger than expected retail performance in Q4 - 2 year(s) ago
“We were obviously seeing positive signs across all of our businesses, all of our businesses did very well,” CFO Shawn Guertin said. “Retail, in particular, has outperformed in the fourth quarter.”
Source: FierceHealthcareCategories: General Medicine News, Latest HeadlinesTweet-
#JPM22: The retail boost at @CVSHealth is being driven by higher-than-anticipated COVID-19 vaccinations and testing. https://t.co/ucRSQq0xNf
-
-
Mashup Score: 1Virtual Event - STAT@JPM: Will 2022 bring biotech renewal? - 2 year(s) ago
Come explore what’s happening in biotech and health tech, and hear the latest about JPM 2022, with STAT’s team of ace reporters.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1JPM 2022: Aledade scoops up advance care planning startup Iris Healthcare to build out health services unit - 2 year(s) ago
Aledade, the startup company that is working to reshape primary care, notched its first tuck-in acquisition by scooping up Iris Healthcare, the company announced Tuesday.
Source: FierceHealthcareCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 10Health tech M&A is heating up - 2 year(s) ago
In the latest edition of STAT Health Tech: a fresh round of acquisitions, 23andMe’s cancer drug trials, and Oak Street Health’s expansion.
Source: STATCategories: Future of Medicine, Latest HeadlinesTweet
#JPM22 Day 3 is well underway. Our reporters have the round up for you so far: https://t.co/6iDSn4OX3q